Milestone Pharmaceuticals Inc
MIST
查看详细走势图
2.070USD
-0.080-3.72%
收盘 12/22, 16:00（美东）报价延迟15分钟
176.30M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-3.72%
5天
-14.11%
1月
-13.75%
6月
+22.49%
今年开始到现在
-12.29%
1年
+15.00%
查看详细走势图
TradingKey Milestone Pharmaceuticals Inc股票评分
单位: USD 更新时间: 2025-12-19操作建议
Milestone Pharmaceuticals Inc当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名135/404位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价3.75。中期看，股价处于平稳状态。近一个月，市场表现较差，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Milestone Pharmaceuticals Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
5
位分析师
买入
评级
3.750
目标均价
+40.98%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Milestone Pharmaceuticals Inc亮点
亮点风险
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
估值低估
公司最新PE估值-2.74，处于3年历史低位
机构减仓
最新机构持股19.38M股，环比减少22.53%
活跃度降低
近期活跃度降低，过去20天平均换手率0.24
Milestone Pharmaceuticals Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Milestone Pharmaceuticals Inc简介
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
公司代码MIST
公司Milestone Pharmaceuticals Inc
CEOOliveto (Joseph)
网址https://www.milestonepharma.com
常见问题
Milestone Pharmaceuticals Inc(MIST)的当前股价是多少？
Milestone Pharmaceuticals Inc(MIST)的当前股价是 2.070。
Milestone Pharmaceuticals Inc的股票代码是什么？
Milestone Pharmaceuticals Inc的股票代码是MIST。
Milestone Pharmaceuticals Inc股票的52周最高点是多少？
Milestone Pharmaceuticals Inc股票的52周最高点是3.060。
Milestone Pharmaceuticals Inc股票的52周最低点是多少？
Milestone Pharmaceuticals Inc股票的52周最低点是0.625。
Milestone Pharmaceuticals Inc的市值是多少？
Milestone Pharmaceuticals Inc的市值是176.30M。
Milestone Pharmaceuticals Inc的净利润是多少？
Milestone Pharmaceuticals Inc的净利润为-41.52M。
现在Milestone Pharmaceuticals Inc(MIST)的股票是买入、持有还是卖出？
根据分析师评级，Milestone Pharmaceuticals Inc(MIST)的总体评级为买入，目标价格为3.750。
Milestone Pharmaceuticals Inc(MIST)股票的每股收益（EPS TTM）是多少
Milestone Pharmaceuticals Inc(MIST)股票的每股收益（EPS TTM）是-0.785。
相关品种
